research suggests that monoacylglycerol lipase may be a potential therapeutic target and prognostic indicator for hepatocellular carcinoma. this finding could have implications for the treatment and diagnosis of the disease. monoacylglycerol lipase is being studied as a possible key factor in hepatocellular carcinoma.